Back
Grifols SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
81
GRFS
Grifols SA
Last Price:
7.01
Seasonality Move:
2.3%
Sell
50
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.12
Seasonality Move:
3.75%
Buy
81
Grifols SA (GRFS)
is a Buy
Is Grifols SA a Buy, Sell or Hold?
- The current Grifols SA [GRFS] share price is $7.00. The Score for GRFS is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- GRFS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
50
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.12. The Score for ADAP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRFS Stock Price Chart
What is Grifols SA's stock price today?
-
The Grifols SA share price today is $7.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRFS is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
GRFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 56.25 | Buy |
| Chaikin Money Flow: | 237004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.38 - 6.94) | Buy |
| Bollinger Bands (100): | (6.19 - 9.23) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 44.88 | Sell |
| Chaikin Money Flow: | -203508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.24) | Sell |
| Bollinger Bands (100): | (0.81 - 1.47) | Sell |
GRFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.79 | Buy |
| 20-day SMA: | 6.59 | Buy |
| 50-day SMA: | 6.55 | Buy |
| 200-day SMA: | 8.57 | Sell |
| 8-day EMA: | 6.81 | Buy |
| 20-day EMA: | 6.7 | Buy |
| 50-day EMA: | 6.91 | Buy |
| 200-day EMA: | 8.06 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Sell |
| 20-day SMA: | 1.09 | Buy |
| 50-day SMA: | 1.31 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.13 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 1.09 | Buy |
Grifols SA Earnings Growth & GRFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.86 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Grifols SA Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||